Trial ID or NCT#

NCT02221869

Status

RECRUITING

Purpose

The purpose of this trial is to assess the efficacy and safety of Xyrem in pediatrics subjects with narcolepsy that includes cataplexy.

Eligibility Criteria

Ages Eligible for Study: 7 Years to 17 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Chad Ruoff, MD

Contact us to find out if this trial is right for you.

CONTACT

Paul Stowers
(650) 721-7551